Five-year outcomes of a personalized pro re nata treatment regimen with anti-vascular endothelial growth factor for neovascular age-related macular degeneration-Reference-Cited by-同舟云学术

Five-year outcomes of a personalized pro re nata treatment regimen with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Published:2018-10-03 Issue:1 Volume:97 Page:e131-e133
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Stattin Martin¹²,Forster Julia¹,Graf Alexandra³,Ahmed Daniel¹²,Krebs Ilse¹²,Ansari-Shahrezaei Siamak¹²⁴^ORCID

Affiliation:

1. Karl Landsteiner Institute for Retinal Research and Imaging; Vienna Austria

2. Department of Ophthalmology; Rudolf Foundation Hospital; Vienna Austria

3. Center for Medical Statistic, Informatics, and Intelligent Systems; Medical University of Vienna; Vienna Austria

4. Department of Ophthalmology; Medical University of Graz; Graz Austria

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aos.13840/fullpdf

Reference5 articles.

1. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study;Brown;Ophthalmology,2009

2. A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related macular degeneration;Chin-Yee;Br J Ophthalmol,2016

3. The clinical effectiveness of ranibizumab treat and extend regimen in nAMD: systematic review and network meta-analysis;Danyliv;Adv Ther,2017

4. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study;Klaver;Arch Ophthalmol,1998

5. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of a calculation model to estimate the impact of the COVID-19 pandemic lockdown on visual acuity in neovascular AMD;European Journal of Ophthalmology;2021-11-02

2. The Effect of Treatment Discontinuation During the COVID-19 Pandemic on Visual Acuity in Exudative Neovascular Age-Related Macular Degeneration: 1-Year Results;Ophthalmology and Therapy;2021-08-09

3. LncRNA NEAT1 Sponges MiRNA-148a-3p to Suppress Choroidal Neovascularization and M2 macrophage polarization;Molecular Immunology;2020-11

4. Long-Term Follow-up of Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Anti–Vascular Endothelial Growth Factor Injections;Ophthalmology Retina;2020-11

5. Analysis of Long Noncoding RNAs in Choroid Neovascularization;Current Eye Research;2020-05-07